David Galvin

David graduated from the Royal College of Surgeons in Ireland (RCSI) in 1996 and was awarded a MD degree at the Mater Hospital and University College Dublin in 2006. He was awarded the FRCS(Urol) from the RCSI in 2008. He completed his Fellowship in Urological Oncology Surgery in Memorial Sloan Kettering Cancer Centre in New York in 2011. Subsequently appointed a Consultant in Urological Oncology in Essex Cancer center and later in the Mater and St. Vincent’s University hospitals as part of the National Cancer Control Program (NCCP).
Other appointments include:
o Associate Professor in College of Medicine, UCD.
o Principal Investigator of the Irish Prostate Cancer Outcomes Research (IPCOR) study, funded by Movember and the Irish Cancer Society for €1.75 million in 2016, and again in 2024 to the value of €3 million.
o Chair, National Cancer Urology Leads group from 2012 to 2018, and co-chaired the Prostate biopsy infection committee in the NCCP.
o Currently Chair the National Prostate cancer guidelines committee at the NCCP.
o Awarded HRB SDAP grant in 2023 valued at €250,000.
o Director of the EU PRAISE-U Prostate cancer screening pilot in Ireland.